From Wikipedia, the free encyclopedia
Nipradilol
|
Names
|
IUPAC name
[8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate
|
Identifiers
|
|
|
|
|
ChemSpider
|
|
|
|
UNII
|
|
InChI=1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3 Key: OMCPLEZZPVJJIS-UHFFFAOYSA-N
|
CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O
|
Properties
|
|
C15H22N2O6
|
Molar mass
|
326.349 g·mol−1
|
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Nipradilol is a
beta blocker and
nitric oxide donor.
[1]
References
|
---|
α1 | Agonists | |
---|
Antagonists |
-
Abanoquil
-
Ajmalicine
-
Alfuzosin
-
Anisodamine
-
Anisodine
-
Atiprosin
-
Atypical antipsychotics (e.g.,
brexpiprazole,
clozapine,
olanzapine,
quetiapine,
risperidone)
-
Benoxathian
-
Beta blockers (e.g.,
adimolol,
amosulalol,
arotinolol,
carvedilol,
eugenodilol,
labetalol)
-
Buflomedil
-
Bunazosin
-
Corynanthine
-
Dapiprazole
-
Domesticine
-
Doxazosin
-
Ergolines (e.g.,
acetergamine,
ergotamine,
dihydroergotamine,
lisuride,
nicergoline,
terguride)
-
Etoperidone
-
Fenspiride
-
Hydroxyzine
-
Indoramin
-
Ketanserin
-
L-765,314
-
mCPP
-
Mepiprazole
-
Metazosin
-
Monatepil
-
Moxisylyte
-
Naftopidil
-
Nantenine
-
Neldazosin
-
Niaprazine
-
Niguldipine
-
Pardoprunox
-
Pelanserin
-
Perlapine
-
Phendioxan
-
Phenoxybenzamine
-
Phentolamine
-
Phenylpiperazine
antidepressants (e.g.,
hydroxynefazodone,
nefazodone,
trazodone,
triazoledione)
-
Piperoxan
-
Prazosin
-
Quinazosin
-
Quinidine
-
Silodosin
-
Spegatrine
-
Spiperone
-
Talipexole
-
Tamsulosin
-
Terazosin
-
Tiodazosin
-
Tolazoline
-
Tetracyclic antidepressants (e.g.,
amoxapine,
maprotiline,
mianserin)
-
Tricyclic antidepressants (e.g.,
amitriptyline,
clomipramine,
doxepin,
imipramine,
trimipramine)
-
Trimazosin
-
Typical antipsychotics (e.g.,
chlorpromazine,
fluphenazine,
loxapine,
thioridazine)
-
Urapidil
-
WB-4101
-
Zolertine
|
---|
|
---|
α2 | Agonists | |
---|
Antagonists |
-
1-PP
-
Adimolol
-
Amesergide
-
Aptazapine
-
Atipamezole
-
Atypical antipsychotics (e.g.,
asenapine,
brexpiprazole,
clozapine,
lurasidone,
olanzapine,
paliperidone,
quetiapine,
risperidone,
zotepine)
-
Azapirones (e.g.,
buspirone,
gepirone,
ipsapirone,
tandospirone)
-
BRL-44408
-
Buflomedil
-
Cirazoline
-
Efaroxan
-
Esmirtazapine
-
Fenmetozole
-
Fluparoxan
-
Idazoxan
-
Ketanserin
-
Lisuride
-
mCPP
-
Mianserin
-
Mirtazapine
-
NAN-190
-
Pardoprunox
-
Phentolamine
-
Phenoxybenzamine
-
Piperoxan
-
Piribedil
-
Rauwolscine
-
Rotigotine
-
Setiptiline
-
Spegatrine
-
Spiroxatrine
-
Sunepitron
-
Terguride
-
Tolazoline
-
Typical antipsychotics (e.g.,
chlorpromazine,
fluphenazine,
loxapine,
thioridazine)
-
Yohimbine
|
---|
|
---|
β | |
---|
|
|
---|
Forms | |
---|
Targets | |
---|
NO donors (
prodrugs) | |
---|
Enzyme (
inhibitors) | |
---|
Others |
- Indirect/downstream NO modulators:
ACE inhibitors/
AT-II receptor antagonists (e.g.,
captopril,
losartan)
-
ETB receptor antagonists (e.g.,
bosentan)
-
L-Type calcium channel
blockers (e.g.,
dihydropyridines:
nifedipine)
-
Nebivolol (
beta blocker)
-
PDE5 inhibitors (e.g.,
sildenafil)
- non-selective PDE inhibitors (e.g.,
caffeine)
- PDE9 inhibitors (e.g.,
paraxanthine)
- cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil)
-
Statins (e.g.,
simvastatin)
|
---|
|